CN113143986A - Medicine for treating pulmonary tuberculosis - Google Patents

Medicine for treating pulmonary tuberculosis Download PDF

Info

Publication number
CN113143986A
CN113143986A CN202110499504.2A CN202110499504A CN113143986A CN 113143986 A CN113143986 A CN 113143986A CN 202110499504 A CN202110499504 A CN 202110499504A CN 113143986 A CN113143986 A CN 113143986A
Authority
CN
China
Prior art keywords
pulmonary tuberculosis
medicine
white
treating pulmonary
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202110499504.2A
Other languages
Chinese (zh)
Inventor
王晓露
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Medical University
Original Assignee
Guangdong Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong Medical University filed Critical Guangdong Medical University
Priority to CN202110499504.2A priority Critical patent/CN113143986A/en
Publication of CN113143986A publication Critical patent/CN113143986A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/42Cucurbitaceae (Cucumber family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/57Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/39Convolvulaceae (Morning-glory family), e.g. bindweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a medicine for treating pulmonary tuberculosis, which consists of cochinchina momordica seed, rat tail, white cock gall and black and white pharbitis seed. The traditional Chinese medicine composition has wide medicine sources and low price, only 4 medicines are adopted, the medicine composition can be reasonably compatible, the components have a better treatment effect on the pulmonary tuberculosis under the mutual synergistic effect, and the traditional Chinese medicine composition is convenient to use and has no toxic or side effect.

Description

Medicine for treating pulmonary tuberculosis
Technical Field
The invention relates to the technical field of medicines, in particular to a medicine for treating pulmonary tuberculosis.
Background
Tuberculosis is a chronic infectious disease caused by mycobacterium tuberculosis, can invade many organs, and is the most common pulmonary tuberculosis infection. The bacteria expeller is an important source of infection. The disease does not always occur after the human body is infected with tubercle bacillus, and clinical onset can be caused when the resistance is reduced or the cell-mediated allergic reaction is increased. The early stage of the disease has no obvious symptoms, and only periodical X-ray examination is needed. The pathological changes are accompanied by symptoms such as lassitude, hot flashes, emaciation, cough, hemoptysis, etc. The most dangerous infection period of tuberculosis patients is the stage where the germ-free patients are not discovered. After a definite diagnosis, the treatment is started, and some necessary preventive measures are taken, so that the possibility of infection is basically eliminated, and the disease is called as tuberculosis in traditional Chinese medicine. At present, the medicines for treating pulmonary tuberculosis in the market are mainly western medicines which have the defects of high price, large side effect and the like, are used for treating symptoms and root causes, are required to be taken for a long time, are easy to relapse after being taken once, and have unsatisfactory treatment effect.
Disclosure of Invention
Therefore, based on the background, the invention provides a medicine for treating pulmonary tuberculosis, which has the advantages of low price, good treatment effect, convenient use and the like.
The technical scheme provided by the invention is as follows:
a medicine for treating pulmonary tuberculosis comprises semen Momordicae, mouse tail, fel gallus Domesticus, and semen Pharbitidis.
Furthermore, it is composed of 2-5 semen Momordicae, 1-3 mouse tails, 1-10 white cock gall bladder, and 1-10 black and white semen Pharbitidis.
Furthermore, the dosage form is a plaster.
Furthermore, during treatment, the plaster-type medicine is only needed to be pasted on the soles of the feet of the patients, left and right for men and women, and then the patients are bedridden for 18 hours, so that the use is convenient, and the gastrointestinal discomfort of part of the patients caused by oral medicines can be avoided.
By adopting the technical scheme, the method has the following beneficial effects:
the medicine has wide medicine source and low price, can be reasonably compatible by only adopting 4 medicines, has better treatment effect on the pulmonary tuberculosis under the mutual synergistic action of the components, and has convenient use and no toxic or side effect.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the examples in the embodiments of the present invention, and it is obvious that the described embodiments are some, but not all, embodiments of the present invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1: a medicine for treating pulmonary tuberculosis comprises semen Momordicae, mouse tail, fel gallus Domesticus, and semen Pharbitidis.
In one dose of the medicine, the dosages of the rat tail and the white cock gall bladder are respectively 3 and 10, 5 black and white pharbitis and 5 momordica cochinchinensis.
Or in one dose of the medicine, the dosages of the rat tail and the white cock gall are respectively 3 and 8, the black and white pharbitis seed is 5, and the momordica cochinchinensis is 2.
Or in one dose of the medicine, the dosages of the rat tail and the white cock gall are respectively 2 and 5, the black and white pharbitis 10 and the momordica cochinchinensis is 3.
The preparation form of the invention is a plaster, and the preparation and use methods thereof are as follows:
the momordica cochinchinensis, the tail of a rat, the white cock gall and the white and black pharbitis seed are weighed according to the weight, mixed and smashed into juice, and then the juice is pasted on the soles of a patient, left and right of a man, and each dose is continuously pasted for 18 hours.
In the medicament of the present invention, the drug is,
semen momordicae: cool in nature, bitter in taste, slightly sweet, entering liver, spleen and stomach meridians, it has the actions of resolving masses, relieving swelling, counteracting toxic pathogen and curing sore.
Black and white clown: qian niu Zi, also called Qian niu Zi, is cold in nature and bitter in taste, enters lung, kidney and large intestine meridians, and has the effects of purging water and relaxing bowels, resolving phlegm and clearing away water, killing parasites and eliminating stagnation, etc.
Chicken gall bladder: is slightly cold in nature and bitter in taste, and has the effects of diminishing inflammation, relieving cough, eliminating phlegm, detoxifying, improving eyesight and the like.
Mouse tail: the pharmacology thereof is not disclosed.
Example 2: typical cases
Case 1: the foot of a male with the disease is pasted by the foot paste, the symptom is obviously improved, the male is examined again, the tuberculous pleurisy is recovered, and the disease does not relapse after the male is visited every day.
Case 2: lu Yi, female, 30 years old, with family pulmonary tuberculosis infection history, patients cough, less phlegm, night sweat, more hand sweat, dizziness, through examination, X-ray chest radiography diagnosis of pulmonary tuberculosis, the foot of the invention is applied for many times, then go to hospital for reexamination, reexamination of chest is normal, has not been done up to now.
The present invention and the embodiments thereof have been described above, but the description is not limited thereto, and the embodiments shown in the examples are only one of the embodiments of the present invention, and the actual configuration is not limited thereto. In summary, those skilled in the art should appreciate that they can readily use the disclosed conception and specific embodiments as a basis for designing or modifying other structures for carrying out the same purposes of the present invention without departing from the spirit and scope of the invention as defined by the appended claims.

Claims (3)

1. A medicine for treating pulmonary tuberculosis is characterized by comprising semen Momordicae, mouse tail, white cock gall bladder, and semen Pharbitidis.
2. The drug for treating pulmonary tuberculosis as claimed in claim 1, which is composed of 2-5 semen momordicae, 1-3 mouse tails, 1-10 white cock gall bladder, 1-10 black and white clown.
3. The medicament for treating pulmonary tuberculosis according to claim 1, wherein the medicament is in the form of a patch.
CN202110499504.2A 2021-05-06 2021-05-06 Medicine for treating pulmonary tuberculosis Withdrawn CN113143986A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110499504.2A CN113143986A (en) 2021-05-06 2021-05-06 Medicine for treating pulmonary tuberculosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110499504.2A CN113143986A (en) 2021-05-06 2021-05-06 Medicine for treating pulmonary tuberculosis

Publications (1)

Publication Number Publication Date
CN113143986A true CN113143986A (en) 2021-07-23

Family

ID=76873798

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110499504.2A Withdrawn CN113143986A (en) 2021-05-06 2021-05-06 Medicine for treating pulmonary tuberculosis

Country Status (1)

Country Link
CN (1) CN113143986A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101301362A (en) * 2008-07-03 2008-11-12 吴红霞 Externally used medicament composition for treating allergic asthma
CN103520288A (en) * 2011-07-28 2014-01-22 冯亚西 External drug for treating heart disease and vasculitis, and its application
CN105288202A (en) * 2015-12-03 2016-02-03 济南星懿医药技术有限公司 Pharmaceutical composition for curing infantile cough

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101301362A (en) * 2008-07-03 2008-11-12 吴红霞 Externally used medicament composition for treating allergic asthma
CN103520288A (en) * 2011-07-28 2014-01-22 冯亚西 External drug for treating heart disease and vasculitis, and its application
CN105288202A (en) * 2015-12-03 2016-02-03 济南星懿医药技术有限公司 Pharmaceutical composition for curing infantile cough

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
杨银田: "葶苈子加鸡苦胆治疗百日咳", 《基层医学论坛》 *
邹志东: "清肺消滞法治疗小儿咳喘", 《北京中医》 *
郑庆良: "《民间偏方秘方精选》", 31 August 2002 *

Similar Documents

Publication Publication Date Title
CN111388582B (en) Traditional Chinese medicine composition for treating novel coronavirus pneumonia and application of preparation thereof
Von Gruenigen et al. Complementary and alternative medicine use in the Amish
CN113143986A (en) Medicine for treating pulmonary tuberculosis
CN103142707B (en) Traditional Chinese medicine paste or treating chronic soft tissue injury and preparation method thereof
CN104147530A (en) Medicine for treating ectopic pregnancy and application thereof
CN114366799A (en) Plateau manna medicated bath preparation and preparation process thereof
CN114652674A (en) Blood circulation promoting and pain relieving ointment and preparation method thereof
CN105853902A (en) Plaster for treating lumbar disc herniation and preparation method thereof
Rostami et al. Diagnosis And Treatment Of Guillain-Barre Syndrome And Neurological Problems With A Clinical Approach: A Systematic Review
CN1480204A (en) Preparation of Chinese herbal medicine for treating barrenness of women
CN101249236B (en) Chinese and western medicine combined preparations for curing epileptic
Wen-jun et al. Preliminary study on treatment of partial androgen deficiency in aging males with Jingui Shenqi Pill
CN108939011A (en) A kind of Chinese herbal medicine formula for the treatment of cancer
CN107875200A (en) A kind of Chinese medicine composition of effectively treatment tinea pedis
CN102727710B (en) Medicine for treating aplastic anemia
CN101890076B (en) Traditional Chinese medicine oral preparation for treating sores and ulcers
Joshi et al. Ayurvedic Management of Ovarian Cyst
CN105920150A (en) Oral liquid for treating functional uterine bleeding and preparation method thereof
Dimble et al. Study of role of Panchatikta Basti in Abhishyanda Pradhana Prameha
Yadav et al. A comparative clinical study for haemostatic action of Lajjalu Lepa and Darvi Lepa in Raktarsha
CN1387897A (en) Wind-fire toothache powder and its prepn
CN104689253A (en) Traditional Chinese medicine composition for treating gallbladder removal syndromes
CN1256137C (en) Chinese medicine for treating pulmonary fuberculosis
CN1615969A (en) Chinese medicine preparation pus drawing out plaster for treating pasteur cystic, furuncle, furunculosis and carbuncle
CN1305517C (en) Mastoproliferation treating medicine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20210723

WW01 Invention patent application withdrawn after publication